Literature DB >> 17250504

Recurrent respiratory infections and phagocytosis in childhood.

Massimiliano Don1, Lolita Fasoli, Viviana Gregorutti, Federica Pisa, Francesca Valent, Mario Prodan, Mario Canciani.   

Abstract

BACKGROUND: About 10% of pre-school children has recurrent respiratory infections (RRI), which could be related to environmental and/or immunological factors. The aim of the present study has been to evaluate the impact of phagocytosis (FAG) and reactive oxygen intermediates (ROI) production deficiencies on pediatric RRI by the measurement of FAG and ROI activity of the polymorphonuclear neutrophils.
METHODS: Serum immunoglobulins, IgG subclasses, lymphocytic subpopulations, FAG and ROI tests were measured in 90 children with RRI, in a moment of well-being and off all medications for at least 4 weeks. FAG and ROI tests were also measured in 19 healthy children.
RESULTS: FAG (91.4 +/- 11.5%) and ROI (81.8 +/- 17.5%) of patients resulted in significantly decreased measurements compared to the control values (95.2 +/- 1.8% and 89.7 +/- 4.8%, respectively). No significant difference was manifest between the mean values of FAG and ROI tests among the patients when they were divided for age (above and below 6 years). A significant decreased likelihood of abnormal ROI (odds ratio, 0.3; 95% confidence interval, 0.07-0.97) was found in the patients with low IgA.
CONCLUSIONS: The authors' results permit only to suppose an etiological role of FAG and ROI deficiencies of polymorphonuclear neutrophils in the genesis of pediatric RRI, irrespective of the age of the patients, and further studies are necessary for confirmation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17250504     DOI: 10.1111/j.1442-200X.2007.02296.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  1 in total

1.  Recurrent respiratory tract infections in children - analysis of immunological examinations.

Authors:  Agata Raniszewska; Elżbieta Górska; Iwona Kotuła; Anna Stelmaszczyk-Emmel; Katarzyna Popko; Olga Ciepiela
Journal:  Cent Eur J Immunol       Date:  2015-08-03       Impact factor: 2.085

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.